Liver Disease
From the Journals
Study eyes biomarkers of regorafenib response in hepatocellular carcinoma
Among 266 proteins tested, decreased levels of 5 correlated with significantly longer overall survival on regorafenib therapy.
From the Journals
For patients with HBV, daily aspirin may reduce risk of liver cancer
Sixteen years of data showed that daily aspirin therapy reduced the risk of HBV-related hepatocellular carcinoma by 29%.
From the Journals
For patients with end-stage liver disease, acute care incurs steep costs
Mean end-of-life costs exceeded those for ischemic heart disease, diabetes, mental health disorders, and congestive heart failure. Only chronic...
From the Journals
Cirrhosis model predicts decompensation across diverse populations
During model development, the hazard ratio for decompensation was 7.10 among patients with high risk scores.
Conference Coverage
Will inpatient albumin help in decompensated cirrhosis?
PHILADELPHIA – Recent studies provide conflicting results, though a randomized, phase 3 trial in progress may...
Video
Dr. Julie Thompson Discusses Primary Biliary Cholangitis
Dr. Julie A. Thompson of the University of Minnesota reviews key issues surrounding PBC.
Conference Coverage
HCC with no cirrhosis is more common in HIV patients
SEATTLE –
From the AGA Journals
High-calorie diet may worsen Wilson disease
The results of the study in rats could explain striking phenotype-genotype discrepancies between patients with Wilson disease, and may give reason...
From the Journals
Women survive more often than men do when hospitalized with cirrhosis
Women more often had infections and comorbidities, while men more often had liver decompensation, which contributed most significantly to their...
From the Journals
Possible biomarkers found for progression to liver cancer in chronic HCV infection
Mannose-binding lectin and ficolin-2 are potential biomarkers for the development of liver cancer in chronic HCV infection.